Shouyao Holdings Gets Regulatory Nod for China Clinical Trial of Lung Cancer Drug-- Shouyao Holdings Beijing obtained approval from China's National Medical Products Administration to carry out clinical trials of SY-5007, the Chinese drugmaker said Thursday. The trial will look...